Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
The use of amyloid PET to assess patient suitability of disease-modifying drugs for Alzheimer diseas...
BackgroundAlzheimer's disease (AD) lacks effective disease-modifying therapies and scalable, ecologi...
BackgroundAlzheimer's disease (AD) is the most common cause of dementia whose prevalence is projecte...
BackgroundNeuropsychiatric symptoms (NPS) are common in Alzheimer's disease (AD) and mild cognitive ...
Accurate quantification of structurally similar metabolites as biomarkers in biofluids has remained ...
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by complex mol...
OBJECTIVE: High accuracy in medical classification tasks does not ensure that neural networks reason...
Deep learning methods have significantly advanced the analysis of brain imaging data for various dow...
BACKGROUND: The rising co-occurrence of cardiometabolic diseases and musculoskeletal degeneration po...
Microglial cells are key players in maintaining brain homeostasis and responding to pathological con...
Current Alzheimer's disease therapies offer limited efficacy and are often accompanied by significan...
OBJECTIVE: To develop an artificial intelligence (AI)-aided dual-task gait test model for scalable, ...
BackgroundAlthough studies have explored tea and coffee in relation to Alzheimer's disease, no centu...
BackgroundPost-stroke cognitive impairment (PSCI) is a major vascular contributor to dementia, signi...
BACKGROUND: Thyroid carcinoma (TC) presents a rising global incidence, with a subset of cases progre...
Alzheimer disease (AD) and Postoperative delirium (POD) may share a common mechanism, but their shar...
Dysregulated lipid metabolism drives atherosclerosis (AS). Yacon, an Andean lipid-modulating tuber, ...
Despite robust preclinical evidence, many clinical trials, including several that targeted the purin...
BACKGROUND: Early identification of Alzheimer's disease-related cognitive impairment remains challen...
BACKGROUND: Early recognition of Alzheimer's disease (AD) is crucial for timely intervention and del...
BACKGROUND: Alzheimer disease (AD) is a progressive neurodegenerative disorder with rapidly growing ...